These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

464 related items for PubMed ID: 33774025

  • 1. E2F2 drives glioma progression via PI3K/AKT in a PFKFB4-dependent manner.
    Zhang L, Liu Z, Dong Y, Kong L.
    Life Sci; 2021 Jul 01; 276():119412. PubMed ID: 33774025
    [Abstract] [Full Text] [Related]

  • 2. CBX2 Induces Glioma Cell Proliferation and Invasion Through the Akt/PI3K Pathway.
    Wang L, Ren B, Zhuang H, Zhong Y, Nan Y.
    Technol Cancer Res Treat; 2021 Jul 01; 20():15330338211045831. PubMed ID: 34709960
    [Abstract] [Full Text] [Related]

  • 3. E2F2 inhibition induces autophagy via the PI3K/Akt/mTOR pathway in gastric cancer.
    Li H, Zhao S, Shen L, Wang P, Liu S, Ma Y, Liang Z, Wang G, Lv J, Qiu W.
    Aging (Albany NY); 2021 Apr 21; 13(10):13626-13643. PubMed ID: 34091441
    [Abstract] [Full Text] [Related]

  • 4. PTPN1 promotes the progression of glioma by activating the MAPK/ERK and PI3K/AKT pathways and is associated with poor patient survival.
    Jin T, Li D, Yang T, Liu F, Kong J, Zhou Y.
    Oncol Rep; 2019 Aug 21; 42(2):717-725. PubMed ID: 31173266
    [Abstract] [Full Text] [Related]

  • 5. miRNA-451 inhibits glioma cell proliferation and invasion by downregulating glucose transporter 1.
    Guo H, Nan Y, Zhen Y, Zhang Y, Guo L, Yu K, Huang Q, Zhong Y.
    Tumour Biol; 2016 Oct 21; 37(10):13751-13761. PubMed ID: 27476171
    [Abstract] [Full Text] [Related]

  • 6. Mir-20a-5p induced WTX deficiency promotes gastric cancer progressions through regulating PI3K/AKT signaling pathway.
    Li J, Ye D, Shen P, Liu X, Zhou P, Zhu G, Xu Y, Fu Y, Li X, Sun J, Xu J, Zhang Q.
    J Exp Clin Cancer Res; 2020 Oct 08; 39(1):212. PubMed ID: 33032635
    [Abstract] [Full Text] [Related]

  • 7. Remodeling cancer stemness by collagen/fibronectin via the AKT and CDC42 signaling pathway crosstalk in glioma.
    Zhong C, Tao B, Tang F, Yang X, Peng T, You J, Xia K, Xia X, Chen L, Peng L.
    Theranostics; 2021 Oct 08; 11(4):1991-2005. PubMed ID: 33408794
    [Abstract] [Full Text] [Related]

  • 8. TRIM59 predicts poor prognosis and promotes pancreatic cancer progression via the PI3K/AKT/mTOR-glycolysis signaling axis.
    Li R, Weng L, Liu B, Zhu L, Zhang X, Tian G, Hu L, Li Q, Jiang S, Shang M.
    J Cell Biochem; 2020 Feb 08; 121(2):1986-1997. PubMed ID: 31693252
    [Abstract] [Full Text] [Related]

  • 9. MicroRNA-30a suppresses self-renewal and tumorigenicity of glioma stem cells by blocking the NT5E-dependent Akt signaling pathway.
    Peng L, Ming Y, Zhang L, Zhou J, Xiang W, Zeng S, He H, Chen L.
    FASEB J; 2020 Apr 08; 34(4):5128-5143. PubMed ID: 32067282
    [Abstract] [Full Text] [Related]

  • 10. Antitumor activity of celastrol by inhibition of proliferation, invasion, and migration in cholangiocarcinoma via PTEN/PI3K/Akt pathway.
    Zhu B, Wei Y.
    Cancer Med; 2020 Jan 08; 9(2):783-796. PubMed ID: 31957323
    [Abstract] [Full Text] [Related]

  • 11. GPR56 promotes proliferation of colorectal cancer cells and enhances metastasis via epithelial‑mesenchymal transition through PI3K/AKT signaling activation.
    Ji B, Feng Y, Sun Y, Ji D, Qian W, Zhang Z, Wang Q, Zhang Y, Zhang C, Sun Y.
    Oncol Rep; 2018 Oct 08; 40(4):1885-1896. PubMed ID: 30066935
    [Abstract] [Full Text] [Related]

  • 12. Elevated expression of GNAS promotes breast cancer cell proliferation and migration via the PI3K/AKT/Snail1/E-cadherin axis.
    Jin X, Zhu L, Cui Z, Tang J, Xie M, Ren G.
    Clin Transl Oncol; 2019 Sep 08; 21(9):1207-1219. PubMed ID: 30767161
    [Abstract] [Full Text] [Related]

  • 13. Effects of Fibronectin 1 on Cell Proliferation, Senescence and Apoptosis of Human Glioma Cells Through the PI3K/AKT Signaling Pathway.
    Liao YX, Zhang ZP, Zhao J, Liu JP.
    Cell Physiol Biochem; 2018 Sep 08; 48(3):1382-1396. PubMed ID: 30048971
    [Abstract] [Full Text] [Related]

  • 14. Sevoflurane downregulates insulin-like growth factor-1 to inhibit cell proliferation, invasion and trigger apoptosis in glioma through the PI3K/AKT signaling pathway.
    Gao C, He XF, Xu QR, Xu YJ, Shen J.
    Anticancer Drugs; 2019 Aug 08; 30(7):e0744. PubMed ID: 31305291
    [Abstract] [Full Text] [Related]

  • 15. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway.
    Li Y, Ma X, Wang Y, Li G.
    Biomed Pharmacother; 2017 Sep 08; 93():435-443. PubMed ID: 28666210
    [Abstract] [Full Text] [Related]

  • 16. VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR-PI3K-AKT pathway.
    Zhangyuan G, Wang F, Zhang H, Jiang R, Tao X, Yu D, Jin K, Yu W, Liu Y, Yin Y, Shen J, Xu Q, Zhang W, Sun B.
    Oncogene; 2020 Feb 08; 39(6):1213-1230. PubMed ID: 31605014
    [Abstract] [Full Text] [Related]

  • 17. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C, Shan Z, Hong J, Yang L.
    Int J Oncol; 2017 Jul 08; 51(1):235-244. PubMed ID: 28534966
    [Abstract] [Full Text] [Related]

  • 18. Targeting of glioma stem-like cells with a parthenolide derivative ACT001 through inhibition of AEBP1/PI3K/AKT signaling.
    Hou Y, Sun B, Liu W, Yu B, Shi Q, Luo F, Bai Y, Feng H.
    Theranostics; 2021 Jul 08; 11(2):555-566. PubMed ID: 33391492
    [Abstract] [Full Text] [Related]

  • 19. Knockdown of hnRNP A2/B1 inhibits cell proliferation, invasion and cell cycle triggering apoptosis in cervical cancer via PI3K/AKT signaling pathway.
    Shi X, Ran L, Liu Y, Zhong SH, Zhou PP, Liao MX, Fang W.
    Oncol Rep; 2018 Mar 08; 39(3):939-950. PubMed ID: 29328485
    [Abstract] [Full Text] [Related]

  • 20. CBX3 promotes glioma U87 cell proliferation and predicts an unfavorable prognosis.
    Zhao SP, Wang F, Yang M, Wang XY, Jin CL, Ji QK, Li S, Zhao XL.
    J Neurooncol; 2019 Oct 08; 145(1):35-48. PubMed ID: 31502042
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.